CLOs on the Move

Exact Sciences

www.exactsciences.com

 
Getting ahead of cancer is crucial no matter where people are in their cancer journey. From earlier cancer detection to treatment guidance and monitoring, we are helping people get the answers they need to make more informed decisions across the cancer continuum. With a leading portfolio of products for earlier detection and treatment guidance, we help people face the most challenging decisions with confidence. Our dedication to taking on the impossible fuels everything we do. We are continuously innovating, combining scientific rigor with an open-minded approach to deliver the next big thing. We are Exact Sciences, and we`re changing lives together through earlier ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Carly Conway
Associate General Counsel, Intellectual Property and Litigation Profile
Andrew Leibfried
Counsel | Director, Coverage and Reimbursement Profile
Henry Weiner
Assistant General Counsel Profile
Allen Zargar
Assistant General Counsel, Contracts Profile
Timothy Caprez
Vice President and Chief Compliance Counsel Profile

Similar Companies

CardioDX

The mission of Crescendo Bioscience, Inc. is to enable more effective management of autoimmune and inflammatory diseases by providing quantitative, objective molecular tests and disease information services to rheumatologists and patients. Crescendo Bioscience is currently focused on rheumatoid arthritis (RA), a debilitating, chronic disease affecting over 1.5 million people in the United States and more than 2 million in Europe. Although there is no known cure for RA, multiple therapies are available, with widely differing levels of effectiveness and significant potential toxicities. Choosing the optimal treatment from among these therapeutic alternatives is a tremendous challenge. At Crescendo Bioscience, we are committed to improving rheumatologists’ ability to understand the biology underlying RA and to better determine the status of a patient’s disease. Vectra® DA is the first and only multi-biomarker blood test validated to measure RA disease activity. Vectra DA integrates the concentrations of 12 serum proteins associated with RA disease activity into a single objective score to help physicians make more informed treatment decisions. Crescendo Bioscience has also developed MyRA™, a free mobile app for people living with RA which was designed to empower patients to regularly track multiple aspects (e.g. medications, morning stiffness, joint pain, daily functionality, etc.) of their RA and easily share the information with their physician.

PetCure Oncology

PetCure Oncology is revolutionizing cancer care for pets by establishing a national network of cancer care centers that specialize in the delivery of stereotactic radiosurgery (SRS). Already proven successful in human medicine, SRS is an advanced form of radiation therapy that is delivered noninvasively with the intent to cure the cancer, resulting in minimal side effects.

Bioarrays

Bioarrays is a Warren, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Ascend Clinical

Ascend Clinical is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Environmental Express

Environmental Express is a Mount Pleasant, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.